300347 泰格醫藥
按盤價 
61.330 -3.570 (-5.501%)
61.330 -3.570 (-5.501%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.865 | 9.972 | 10.643 | 16.787 | 17.202 |
| 總資產報酬率 ROA (%) | 2.713 | 7.089 | 7.840 | 13.292 | 12.943 |
| 投入資產回報率 ROIC (%) | 3.156 | 8.277 | 9.110 | 15.264 | 15.416 | 邊際利潤分析 |
| 銷售毛利率 (%) | 38.880 | 38.577 | 39.637 | 43.553 | 47.435 |
| 營業利潤率 (%) | 21.410 | 33.680 | 36.446 | 70.911 | 69.615 |
| 息稅前利潤/營業總收入 (%) | 22.070 | 32.235 | 34.257 | 66.523 | 72.261 |
| 淨利潤/營業總收入 (%) | 17.822 | 29.116 | 32.062 | 65.056 | 63.560 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 95.768 | 73.534 | 74.609 | 42.767 | 34.769 |
| 價值變動淨收益/利潤總額(%) | 6.876 | 27.765 | 24.701 | 57.746 | 64.076 |
| 營業外收支淨額/利潤總額(%) | 0.190 | 0.064 | 0.115 | -0.337 | -0.162 | 償債能力分析 |
| 流動比率 (X) | 1.365 | 2.741 | 2.978 | 4.498 | 10.222 |
| 速動比率 (X) | 1.361 | 2.735 | 2.972 | 4.495 | 10.218 |
| 資產負債率 (%) | 19.348 | 17.611 | 17.363 | 13.209 | 0.084 |
| 帶息債務/全部投入資本 (%) | 17.170 | 14.353 | 13.711 | 7.799 | 3.430 |
| 股東權益/帶息債務 (%) | 467.626 | 578.707 | 604.915 | 1,136.815 | 2,729.354 |
| 股東權益/負債合計 (%) | 359.606 | 402.258 | 410.935 | 577.926 | 978.316 |
| 利息保障倍數 (X) | 35.652 | -21.973 | -15.350 | -16.030 | 26.198 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 66.651 | 55.786 | 46.665 | 44.885 | 88.281 |
| 存貨周轉天數 (天) | 1.987 | 1.810 | 1.191 | 0.662 | 0.636 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 22/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
